LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · IEX Real-Time Price · USD

15.72

+0.27 (1.75%)

At close: Apr 26, 2024, 4:00 PM

16.03

+0.31 (1.97%)

After-hours: Apr 26, 2024, 4:35 PM EDT

LENZ Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	40.97	32.85	22.51	4.38	0.03
Research & Development	32.14	72.79	37.93	9.12	0
Other Operating Expenses	62.08	0	0	0	0
Operating Expenses	135.19	105.64	60.44	13.5	0.03
Operating Income	-135.19	-105.64	-60.44	-13.5	-0.03
Interest Expense / Income	0	0	0	0.04	0.08
Other Expense / Income	-10.54	-4.59	10.32	54.83	-
Pretax Income	-124.65	-101.05	-70.76	-68.37	-0.11
Net Income	-124.65	-101.05	-70.76	-68.37	-0.11
Shares Outstanding (Basic)	8	8	4	0	-
Shares Outstanding (Diluted)	8	8	4	0	-
Shares Change	3.90%	89.75%	1166.12%	-	-
EPS (Basic)	-15.33	-12.88	-17.15	-209.51	-
EPS (Diluted)	-15.33	-12.88	-17.15	-209.51	-
Free Cash Flow	-98.96	-94.57	-58.59	-10.27	-0.02
Free Cash Flow Per Share	-12.15	-12.06	-14.18	-31.46	-
EBITDA	-117.96	-92.71	-68.57	-68.21	-0.03
Depreciation & Amortization	6.7	8.35	2.19	0.12	0
EBIT	-124.65	-101.05	-70.76	-68.33	-0.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).